Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	(cdp6038	-	-	-	-	[1] 46 💬
2	2-cda	Cladribine	[1] D01370 💬	[1] RRM1 💬	[5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism	[1] 13 💬
3	2-cda, 2-chloro-2'-deoxy-beta-d-adenosine	Adenosine	[2] D00045, D01370 💬	[5] ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬	[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	[1] 13 💬
4	2-cda, 2-chloro-2'-deoxy-ß-d-adenosine	Adenosine	[2] D00045, D01370 💬	[5] ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬	[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	[1] 13 💬
5	2-cda, 2-chloro-2?-deoxy-beta-d-adenosine	Adenosine	[2] D00045, D01370 💬	[5] ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬	[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	[1] 13 💬
6	2-cda, 2-chloro-2?-deoxy-ß-d-adenosine	Adenosine	[2] D00045, D01370 💬	[5] ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬	[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	[1] 13 💬
7	2-cda, 2-chloro-2’-deoxy-beta-d-adenosine	Adenosine	[2] D00045, D01370 💬	[5] ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬	[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	[1] 13 💬
8	2-cda, 2-chloro-2’-deoxy-ß-d-adenosine	Adenosine	[2] D00045, D01370 💬	[5] ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬	[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	[1] 13 💬
9	2-chloro-2'-deoxy-beta-d-adenosine (2-cda)	Adenosine	[2] D00045, D01370 💬	[5] ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬	[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	[1] 13 💬
10	2-chloro-2'-deoxy-ß-d-adenosine (2-cda)	Adenosine	[2] D00045, D01370 💬	[5] ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬	[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	[1] 13 💬
11	2-chloro-2'-deoxyadenosine (2-cda)	Cladribine	[1] D01370 💬	[1] RRM1 💬	[5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism	[1] 13 💬
12	2-chloro-2’-deoxy-beta-d-adenosine (2-cda)	Adenosine	[2] D00045, D01370 💬	[5] ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬	[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	[1] 13 💬
13	2-chloro-2’-deoxy-ß-d-adenosine (2-cda)	Adenosine	[2] D00045, D01370 💬	[5] ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬	[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	[1] 13 💬
14	2-chloro-2’-deoxyadenosine (2-cda)	Cladribine	[1] D01370 💬	[1] RRM1 💬	[5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism	[1] 13 💬
15	Adeno-associated virus serotype 2/6 encoding human alpha-galactosidase a cdna	Agalsidase alfa	[1] D02784 💬	[1] GLA 💬	[6] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism	[1] 19 💬
16	Allo-asc-cd	-	-	-	-	[1] 96 💬
17	Anti cd3 monoclonal antibody	-	-	-	-	[1] 97 💬
18	Anti-cd19-car-t cells	-	-	-	-	[1] 49 💬
19	Anti-cd20 b cell depletion with truxima	-	-	-	-	[1] 49 💬
20	Anti-cd20 small modular immunopharmaceutical, wye-400087	-	-	-	-	[1] 46 💬
21	Anti-cd25 humanized monoclonal antibody	-	-	-	-	[1] 13 💬
22	Anti-cd28dab	-	-	-	-	[3] 49, 53, 160 💬
23	Anti-cd3	Muromonab	[1] D05092 💬	[3] CD3D, CD3E, CD3G 💬	[11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation	[2] 96, 97 💬
24	Anti-cd3 monoclonal antibody	Muromonab	[1] D05092 💬	[3] CD3D, CD3E, CD3G 💬	[11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation	[2] 96, 97 💬
25	Anti-cd40l	Toralizumab	[1] D06193 💬	[1] CD40LG 💬	[13] Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, T cell receptor signaling pathway, Toxoplasmosis, Viral myocarditis	[1] 63 💬
26	Anti-cd40ldab	-	-	-	-	[1] 63 💬
27	Anti-cd45	-	-	-	-	[3] 60, 65, 285 💬
28	Anti-cd52 monoclonal antibody	-	-	-	-	[1] 13 💬
29	Ap-cd/ld	-	-	-	-	[1]  6  💬
30	Autologous cd34+ cell transduced with g2scid vector	-	-	-	-	[1] 65 💬
31	Autologous cd34+ cells transduced ex-vivo with the pcclchimgp91/vsvg lentiviral vector	-	-	-	-	[1] 65 💬
32	Autologous cd34+ cells transduced with a lentiviral vector containing the human sgsh gene	-	-	-	-	[1] 19 💬
33	Autologous cd34+ cells transduced with a lentiviral vector encoding the arsa cdna	-	-	-	-	[1] 19 💬
34	Autologous cd34+ cells transduced with lenti-d vector encoding abcd1 cdna	-	-	-	-	[1] 20 💬
35	Autologous cd34+ cells transduced with the lentiviral vector containing the human wiskott aldrich sy	-	-	-	-	[1] 65 💬
36	Autologous cd34+ enriched cell fraction that contains cd34+ cells transduced with lentiviral vector that encodes for the human wiskott aldrich syndrome (was) cdna sequence	-	-	-	-	[1] 65 💬
37	Autologous cd34+ hscs transduced ex vivo with efs lentiviral vector encoding for the human ada gene	-	-	-	-	[1] 65 💬
38	Autologous cd34+cells transduced with the w1.6_hwasp_wpre (vsvg) lentiviral vector	-	-	-	-	[1] 65 💬
39	Autologous cd34-selected peripheral blood stem cells transplant	-	-	-	-	[1] 96 💬
40	Autologous cd4+t cells stimulated and expanded ex vivo by a mog peptide modified by the introduction of a thioreductase motif into the flanking residues of the t cell epitope	-	-	-	-	[1] 13 💬
41	Autologous haematopoietic stem cells transduced with lentiviral vector lenti-d encoding the human abcd1 cdna	-	-	-	-	[1] 20 💬
42	Autologous stemcell transplantation with cd (cluster of differentiation) 34 selected stem cells	-	-	-	-	[1] 51 💬
43	Bardoxolone methyl, cddo-me, cddo-methyl ester, nsc 713200, chemical name: oleana-1,9(11)-dien-28-oic acid, 2-cyano-3,12-dioxo-, methyl ester	Bardoxolone	[2] D09584, D09585 💬	-	-	[1] 86 💬
44	Biologic: ic14 (monoclonal antibody against human cd14)	-	-	-	-	[1]  2  💬
45	Blinded cdca 250 mg tid	Chenodeoxycholic acid	[1] D00163 💬	[1] NR1H4 💬	[1] Bile secretion	[1] 263 💬
46	Bt061 (cd4 monoclonal antibody)	-	-	-	-	[1] 46 💬
47	Cd	-	-	-	-	[6]  6 , 46, 51, 96, 97, 265 💬
48	Cd-4 guided therapy interruption	-	-	-	-	[1] 265 💬
49	Cd-ld cr	-	-	-	-	[1]  6  💬
50	Cd-ld ir	-	-	-	-	[1]  6  💬
51	Cd19-directed humanised afucosylated monoclonal antibody	-	-	-	-	[1] 11 💬
52	Cd3/cd19 depleted leukocytes	-	-	-	-	[1] 284 💬
53	Cd3/cd19 neg allogeneic bmt	-	-	-	-	[1] 65 💬
54	Cd3/cd19 negative allogeneic hematopoietic stem cells	-	-	-	-	[1] 65 💬
55	Cd3/cd19 negative hematopoietic stem cells	-	-	-	-	[1] 85 💬
56	Cd34 selected autologous hematopoietic cells	-	-	-	-	[1] 51 💬
57	Cd34 stem cell selection therapy	-	-	-	-	[3] 60, 65, 284 💬
58	Cd34+	-	-	-	-	[1] 65 💬
59	Cd34+ bone marrow stem cells intravitreal	-	-	-	-	[1] 90 💬
60	Cd34+ cells	-	-	-	-	[1] 285 💬
61	Cd34+ cells transduced with ada retrovir	-	-	-	-	[1] 65 💬
62	Cd34+ enriched, t cell depleted donor stem cell product	-	-	-	-	[1] 326 💬
63	Cd34+ hscs transduced with the lentivirus vector, vsv-g pseudotyped cl20-4i-ef1a-h?c-opt	-	-	-	-	[1] 65 💬
64	Cd34+ selected cells	-	-	-	-	[1] 285 💬
65	Cd34+cells	-	-	-	-	[2] 65, 285 💬
66	Cd34+sc	-	-	-	-	[1] 51 💬
67	Cd45ra depleted leukocytes	-	-	-	-	[1] 284 💬
68	Cd45ra-depleted dli	-	-	-	-	[2] 60, 65 💬
69	Cd62l- tem	-	-	-	-	[1] 60 💬
70	Cdca	Chenodeoxycholic acid	[1] D00163 💬	[1] NR1H4 💬	[1] Bile secretion	[1] 263 💬
71	Cdca weight-based dose tid	Chenodeoxycholic acid	[1] D00163 💬	[1] NR1H4 💬	[1] Bile secretion	[1] 263 💬
72	Cdmard	-	-	-	-	[1] 46 💬
73	Cdnf	-	-	-	-	[1]  6  💬
74	Cdp	-	-	-	-	[1] 46 💬
75	Cdp 6038 sc	-	-	-	-	[1] 46 💬
76	Cdp3194	-	-	-	-	[1] 49 💬
77	Cdp323	CDP323	-	-	-	[1] 13 💬
78	Cdp6038	-	-	-	-	[2] 46, 96 💬
79	Cdp7657	-	-	-	-	[1] 49 💬
80	Cdp870	-	-	-	-	[3] 46, 96, 271 💬
81	Cdp870 100mg	-	-	-	-	[1] 46 💬
82	Cdp870 200mg	-	-	-	-	[1] 46 💬
83	Cdp870 400mg	-	-	-	-	[1] 46 💬
84	Cdp870 fab'-peg	-	-	-	-	[1] 46 💬
85	Cdx	-	-	-	-	[3] 222, 223, 240 💬
86	Cdx 6114	-	-	-	-	[1] 240 💬
87	Cdx-1135	-	-	-	-	[2] 222, 223 💬
88	Cdz173	-	-	-	-	[2] 53, 65 💬
89	Cellule cd34+ autologhe trasdotte con idua lv codificante per il cdna dell'alfa-l-iduronidasi	-	-	-	-	[1] 19 💬
90	Certolizumab pegol (cdp870)	Certolizumab pegol	[1] D03441 💬	[1] TNF 💬	[65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	[2] 46, 96 💬
91	Certolizumab pegol (cdp870, czp)	Certolizumab pegol	[1] D03441 💬	[1] TNF 💬	[65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	[1] 96 💬
92	Certolizumab pegol (cdp870, tradename cimzia)	Certolizumab pegol	[1] D03441 💬	[1] TNF 💬	[65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	[1] 46 💬
93	Certolizumab pegol (cdp870, tradename cimzia)(prefilled syringes at the dose of 200mg)	Certolizumab pegol	[1] D03441 💬	[1] TNF 💬	[65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	[1] 46 💬
94	Chimeric human/mouse anti-cd-20 monoclonal antibody	-	-	-	-	[1] 46 💬
95	Chx a-dtpa anti-cd66 antibody	Pentetic acid	[1] D05422 💬	-	-	[1] 28 💬
96	Chx-a-dtpa-anti-cd66	Pentetic acid	[1] D05422 💬	-	-	[1] 28 💬
97	Combination of a single dose anti-cd20 antibody and bortezomib	Bortezomib	[1] D03150 💬	[1] PSMB5 💬	[8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia	[1] 61 💬
98	Cryopreserved autologous cd34+ cells transduced with a lentiviral vector containing human sgsh gene	-	-	-	-	[1] 19 💬
99	Cryopreserved efs-ada lv transduced patient cd34+ cells	-	-	-	-	[1] 65 💬
100	Cryopreserved g2scid lentiviral vector transduced patient cd34+ cells	-	-	-	-	[1] 65 💬
101	Cytolytic cd4+ t cells	-	-	-	-	[1] 13 💬
102	Cytoreductive regimen followed by a cd34+e- selected allogeneic stem cell transplant	-	-	-	-	[1] 62 💬
103	D-methylphenidate	Methylphenidate	[2] D01296, D04999 💬	[2] SLC6A2, SLC6A3 💬	[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle	[1] 84 💬
104	Daclizumab (anti-cd25 humanized monoclonal antibody)	Daclizumab	[1] D03639 💬	[1] IL2RA 💬	[11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	[1] 13 💬
105	Depletion in cd45ra graft donor	-	-	-	-	[1] 65 💬
106	Device: cell processing for tcrabeta+/cd19+ depletion	-	-	-	-	[1] 65 💬
107	Device: cell processing for tcraß+/cd19+ depletion	-	-	-	-	[1] 65 💬
108	Device: clinimacs® cd34 reagent system cell sorter device	-	-	-	-	[1] 65 💬
109	Device: miltenyi cd34 reagent system	-	-	-	-	[1] 60 💬
110	Diltiazem	Diltiazem	[3] D00616, D03830, D07845 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	[36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	[3] 51, 58, 86 💬
111	Diltiazem gel 2%	Diltiazem	[3] D00616, D03830, D07845 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	[36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	[1] 51 💬
112	Diltiazem hydrochloride	Diltiazem	[3] D00616, D03830, D07845 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	[36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	[1] 86 💬
113	Duodopa ld/cd 20/5 mg/ml	-	-	-	-	[1]  6  💬
114	Ef1as-ada lentiviral vector gene modified autologous cd34+ cells	-	-	-	-	[1] 65 💬
115	Ef1as-ada lentiviral vector transduced patient cd34+ cells	-	-	-	-	[1] 65 💬
116	Engineered humanized monoclonal anti-human cd19 antibody.	-	-	-	-	[1] 46 💬
117	Engineered humanized monoclonal anti-human cd19 antibody. lot numbers: 1-fin-1588 (9.6mg/ml)	-	-	-	-	[1] 46 💬
118	Er cd-ld	-	-	-	-	[1]  6  💬
119	Ex vivo culture and transduction of the patient's autologous cd34+ hsc with lentivirus vector vsv-g pseudotyped cl20- 4i-ef1a-hyc-opt vector	-	-	-	-	[1] 65 💬
120	Ex-vivo expanded autologous human keratinocytes suspension containing epidermal stem cells genetically modified with a gamma-retroviral (rv) vector expressing the full-length lamb3 cdna.	-	-	-	-	[1] 36 💬
121	Fc- and cdr-modified humanised monoclonal antibody against c5	-	-	-	-	[3] 11, 62, 109 💬
122	G1xcgd transduced cd34+ cells	-	-	-	-	[1] 65 💬
123	Gene-transduced autologous cd34+ stem cells	-	-	-	-	[1] 65 💬
124	Genetic: infusion of autologous cryopreserved efs-ada lv cd34+ cells (otl-101)	-	-	-	-	[1] 65 💬
125	Genetic: infusion of autologous efs-ada lv cd34+ (otl-101)	-	-	-	-	[1] 65 💬
126	Genetic: infusion of autologous efs-ada lv cd34+ cells	-	-	-	-	[1] 65 💬
127	Gsk2018682 cd2 capsule	-	-	-	-	[1] 13 💬
128	Gsk2018682 cd3 micronised tablet	-	-	-	-	[1] 13 💬
129	Gsk2018682 cd3 non-micronised tablet	-	-	-	-	[1] 13 💬
130	Gsk2018682 cd3 non-micronised tablet in fed state	-	-	-	-	[1] 13 💬
131	Human monoclonal antibody directed against cd20 on b-cells	-	-	-	-	[1] 46 💬
132	Humanised anti-cd 20 antibody	-	-	-	-	[1] 46 💬
133	Humanised anti-cd4 igg1 monoclonal	-	-	-	-	[1] 46 💬
134	Humanized recombinant igg4 monoclonal antibody against cd-127	-	-	-	-	[1] 97 💬
135	Humax-cd20	Ofatumumab	[1] D09314 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[2] 13, 46 💬
136	Humax-cd38	-	-	-	-	[2] 28, 63 💬
137	Humax-cd4	-	-	-	-	[1] 46 💬
138	Indium 111-radiolabelled anti-cd66	Indium	-	-	-	[1] 28 💬
139	Indium­ 111 ­labelled anti­-cd66	Indium	-	-	-	[1] 28 💬
140	Inebilizumab	Inebilizumab	[1] D11757 💬	[1] CD19 💬	[5] B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency	[3] 11, 13, 300 💬
141	Ipx203 er cd-ld	-	-	-	-	[1]  6  💬
142	Ir cd-ld	-	-	-	-	[1]  6  💬
143	Ir cd-ld (carbidopa-levodopa) tablets	Carbidopa	[2] D00059, D00558 💬	[6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬	[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway	[1]  6  💬
144	Ir ld / cd	-	-	-	-	[1]  6  💬
145	Ir ld/cd	-	-	-	-	[1]  6  💬
146	Ld/cd	-	-	-	-	[1]  6  💬
147	Lentiviral vector transduced cd34+ cells	-	-	-	-	[1] 65 💬
148	Levodopa/carbidopa (ld/cd)	Carbidopa	[2] D00059, D00558 💬	[6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬	[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway	[1]  6  💬
149	Methylphenidate	Methylphenidate	[2] D01296, D04999 💬	[2] SLC6A2, SLC6A3 💬	[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle	[7]  6 , 13, 34, 84, 113, 179, 206 💬
150	Methylphenidate (mpd)	Methylphenidate	[2] D01296, D04999 💬	[2] SLC6A2, SLC6A3 💬	[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle	[1]  6  💬
151	Methylphenidate (overencapsulated)	Methylphenidate	[2] D01296, D04999 💬	[2] SLC6A2, SLC6A3 💬	[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle	[1] 84 💬
152	Methylphenidate 10mg tablets	Methylphenidate	[2] D01296, D04999 💬	[2] SLC6A2, SLC6A3 💬	[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle	[1] 84 💬
153	Methylphenidate hydrochloride	Methylphenidate	[2] D01296, D04999 💬	[2] SLC6A2, SLC6A3 💬	[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle	[2]  6 , 13 💬
154	Methylphenidate modified release	Methylphenidate	[2] D01296, D04999 💬	[2] SLC6A2, SLC6A3 💬	[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle	[1] 13 💬
155	Methylphenidate modified release 20 mg	Methylphenidate	[2] D01296, D04999 💬	[2] SLC6A2, SLC6A3 💬	[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle	[1] 13 💬
156	Methylphenidate modified release 30 mg	Methylphenidate	[2] D01296, D04999 💬	[2] SLC6A2, SLC6A3 💬	[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle	[1] 13 💬
157	Methylphenidate modified release 40 mg	Methylphenidate	[2] D01296, D04999 💬	[2] SLC6A2, SLC6A3 💬	[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle	[1] 13 💬
158	Methylphenidate, fluoxetin, risperidone	Fluoxetine	[5] D00326, D00426, D00823, D01296, D04999 💬	[5] DRD2, HTR2A, SLC6A2, SLC6A3, SLC6A4 💬	[14] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway	[2] 179, 206 💬
159	Muromonab	Muromonab	[1] D05092 💬	[3] CD3D, CD3E, CD3G 💬	[11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation	[1] 60 💬
160	Muromonab-cd3	Muromonab	[1] D05092 💬	[3] CD3D, CD3E, CD3G 💬	[11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation	[1] 60 💬
161	Ni-0401 (anti-cd3 mab)	Muromonab	[1] D05092 💬	[3] CD3D, CD3E, CD3G 💬	[11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation	[1] 96 💬
162	Ono-2160/cd	-	-	-	-	[1]  6  💬
163	Open-label cdca 250 mg tid	Chenodeoxycholic acid	[1] D00163 💬	[1] NR1H4 💬	[1] Bile secretion	[1] 263 💬
164	Other: cd lfd	-	-	-	-	[1] 96 💬
165	Other: cd-treat diet	-	-	-	-	[1] 96 💬
166	Other: crohn's disease treatment-with-eating diet (cd-treat diet)	-	-	-	-	[1] 96 💬
167	Other: diet-cd	-	-	-	-	[1] 96 💬
168	Phagocyte oxidase subunit transduced cd34 hematopoietic stem cells	-	-	-	-	[1] 65 💬
169	Plerixafor mobilization of autologous cd117 stem cells	Plerixafor	[1] D08971 💬	[1] CXCR4 💬	[12] Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral protein interaction with cytokine and cytokine receptor	[1] 299 💬
170	Procedure: autologous cd34+hpc transplantation (hsct)	-	-	-	-	[1] 49 💬
171	Procedure: cd3-depleted hematopoietic cell transplantation	-	-	-	-	[1] 60 💬
172	Procedure: cd34 selected haploidentical pbsct	-	-	-	-	[1] 285 💬
173	Procedure: cd34+ peripheral blood stem cell reinfusion	-	-	-	-	[1] 49 💬
174	Procedure: cd3±cd19 depleted hematopoietic stem cell transplantation	-	-	-	-	[1] 60 💬
175	Procedure: repair of cdh w/alloderm	-	-	-	-	[1] 294 💬
176	Procedure: repair of cdh w/sis gold	Gold	-	-	-	[1] 294 💬
177	Rag1 lv cd34+ cells	-	-	-	-	[1] 65 💬
178	Recombinant adeno-associated virus 2/6 vector encoding the cdna for human alpha galactosidase a	-	-	-	-	[1] 19 💬
179	Rescue medication cdca 250 mg tid	Chenodeoxycholic acid	[1] D00163 💬	[1] NR1H4 💬	[1] Bile secretion	[1] 263 💬
180	Retroviral sf71-gp91phox transduced cd34+ cells	-	-	-	-	[1] 65 💬
181	Rituximab (anti-cd20)	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 53 💬
182	Routine treatment of cd	-	-	-	-	[1] 96 💬
183	Semi continuous intra-oral administration of ld/cd	-	-	-	-	[1]  6  💬
184	Standard ld/cd	-	-	-	-	[1]  6  💬
185	Suspension of autologous cd34+cells transduced with the g1xcgd viral vector	-	-	-	-	[1] 65 💬
186	T-cell depleted & cd34+select/w/stemcell enriched product	-	-	-	-	[1] 65 💬
187	Tl011, anti cd20, for the treatment of rheumatoid arthritis	-	-	-	-	[1] 46 💬
188	Transduced cd34+ cells	-	-	-	-	[1] 285 💬
189	Transduced patient cd34+ cells	-	-	-	-	[1] 65 💬
190	Yttrium-90 radiolabelled anti-cd66 antibody	Yttrium Y-90	-	-	-	[1] 28 💬
191	Yttrium­90 radiolabelled anti­cd66	-	-	-	-	[1] 28 💬

Back to top